Laraway Financial Advisors’s Merck MRK Stock Holding History

Laraway Financial Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$328K	Sell	2,723 -720	-21%	-$83.1K	0.23%	99
2025 Q4	$362K	Hold	3,443	–	–	0.24%	97
2025 Q3	$289K	Buy	3,443 +301	+10%	+$24.8K	0.2%	108
2025 Q2	$249K	Hold	3,142	–	–	0.19%	110
2025 Q1	$282K	Sell	3,142 -250	-7%	-$23.3K	0.22%	98
2024 Q4	$337K	Hold	3,392	–	–	0.26%	87
2024 Q3	$385K	Sell	3,392 -50	-1%	-$5.94K	0.31%	75
2024 Q2	$426K	Hold	3,442	–	–	0.36%	69
2024 Q1	$454K	Hold	3,442	–	–	0.4%	71
2023 Q4	$375K	Buy	3,442 +76	+2%	+$7.89K	0.36%	74
2023 Q3	$347K	Hold	3,366	–	–	0.36%	73
2023 Q2	$388K	Sell	3,366 -250	-7%	-$28.4K	0.38%	72
2023 Q1	$385K	Sell	3,616 -400	-10%	-$43.2K	0.39%	79
2022 Q4	$446K	Sell	4,016 -4	-0.1%	-$409	0.47%	68
2022 Q3	$346K	Sell	4,020 -20	-0.5%	-$1.78K	0.39%	75
2022 Q2	$368K	Sell	4,040 -100	-2%	-$8.87K	0.39%	78
2022 Q1	$340K	Sell	4,140 -20	-0.5%	-$1.58K	0.31%	85
2021 Q4	$319K	Buy	+4,160	New	+$331K	0.28%	91

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Laraway Financial Advisors's MRK Position: Q1 2026 in Review

Laraway Financial Advisors reduced its Merck (MRK) stake by 21% in Q1 2026, selling an estimated $83.1K and leaving 2,723 shares worth $328K. The position accounts for 0.23% of the portfolio, ranked #99.

Laraway Financial Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $454K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Laraway Financial Advisors held 2,723 shares of Merck worth $328K as of Q1 2026.
Laraway Financial Advisors sold 720 Merck shares in Q1 2026, an estimated $83.1K.
Merck made up 0.23% of Laraway Financial Advisors's portfolio in Q1 2026, its #99 holding.
Laraway Financial Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
Laraway Financial Advisors's Merck position peaked at $454K in Q1 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.